Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.992 |
High Similarity |
NPD2674 |
Phase 3 |
0.9683 |
High Similarity |
NPD3144 |
Approved |
0.9683 |
High Similarity |
NPD3145 |
Approved |
0.8897 |
High Similarity |
NPD7153 |
Discontinued |
0.8478 |
Intermediate Similarity |
NPD2161 |
Phase 2 |
0.824 |
Intermediate Similarity |
NPD228 |
Approved |
0.8138 |
Intermediate Similarity |
NPD4123 |
Phase 3 |
0.8112 |
Intermediate Similarity |
NPD6331 |
Phase 2 |
0.7985 |
Intermediate Similarity |
NPD3676 |
Clinical (unspecified phase) |
0.7956 |
Intermediate Similarity |
NPD5752 |
Clinical (unspecified phase) |
0.791 |
Intermediate Similarity |
NPD2337 |
Clinical (unspecified phase) |
0.7891 |
Intermediate Similarity |
NPD4739 |
Approved |
0.7867 |
Intermediate Similarity |
NPD4675 |
Approved |
0.7867 |
Intermediate Similarity |
NPD4678 |
Approved |
0.7862 |
Intermediate Similarity |
NPD6658 |
Clinical (unspecified phase) |
0.7852 |
Intermediate Similarity |
NPD1669 |
Approved |
0.7842 |
Intermediate Similarity |
NPD5718 |
Phase 2 |
0.7838 |
Intermediate Similarity |
NPD7526 |
Approved |
0.7838 |
Intermediate Similarity |
NPD52 |
Approved |
0.7838 |
Intermediate Similarity |
NPD7527 |
Clinical (unspecified phase) |
0.7793 |
Intermediate Similarity |
NPD3060 |
Approved |
0.7752 |
Intermediate Similarity |
NPD9377 |
Approved |
0.7752 |
Intermediate Similarity |
NPD9379 |
Approved |
0.7724 |
Intermediate Similarity |
NPD4664 |
Clinical (unspecified phase) |
0.7712 |
Intermediate Similarity |
NPD5773 |
Approved |
0.7712 |
Intermediate Similarity |
NPD5772 |
Approved |
0.7692 |
Intermediate Similarity |
NPD7201 |
Clinical (unspecified phase) |
0.7682 |
Intermediate Similarity |
NPD824 |
Approved |
0.7664 |
Intermediate Similarity |
NPD2922 |
Phase 1 |
0.766 |
Intermediate Similarity |
NPD7477 |
Discontinued |
0.766 |
Intermediate Similarity |
NPD839 |
Approved |
0.766 |
Intermediate Similarity |
NPD840 |
Approved |
0.7658 |
Intermediate Similarity |
NPD4083 |
Discontinued |
0.7655 |
Intermediate Similarity |
NPD1375 |
Discontinued |
0.7643 |
Intermediate Similarity |
NPD2669 |
Clinical (unspecified phase) |
0.7606 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.76 |
Intermediate Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.7569 |
Intermediate Similarity |
NPD6896 |
Approved |
0.7569 |
Intermediate Similarity |
NPD6895 |
Approved |
0.7568 |
Intermediate Similarity |
NPD5241 |
Discontinued |
0.7564 |
Intermediate Similarity |
NPD7831 |
Phase 2 |
0.7564 |
Intermediate Similarity |
NPD7832 |
Clinical (unspecified phase) |
0.7564 |
Intermediate Similarity |
NPD4055 |
Discovery |
0.7564 |
Intermediate Similarity |
NPD7833 |
Phase 2 |
0.7556 |
Intermediate Similarity |
NPD2668 |
Approved |
0.7556 |
Intermediate Similarity |
NPD2667 |
Approved |
0.7551 |
Intermediate Similarity |
NPD4162 |
Approved |
0.7536 |
Intermediate Similarity |
NPD5310 |
Approved |
0.7536 |
Intermediate Similarity |
NPD5311 |
Approved |
0.7534 |
Intermediate Similarity |
NPD3656 |
Approved |
0.7533 |
Intermediate Similarity |
NPD1754 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD2157 |
Approved |
0.75 |
Intermediate Similarity |
NPD1712 |
Approved |
0.7484 |
Intermediate Similarity |
NPD6818 |
Clinical (unspecified phase) |
0.7482 |
Intermediate Similarity |
NPD3055 |
Approved |
0.7482 |
Intermediate Similarity |
NPD3053 |
Approved |
0.7481 |
Intermediate Similarity |
NPD821 |
Approved |
0.7468 |
Intermediate Similarity |
NPD4773 |
Phase 2 |
0.7468 |
Intermediate Similarity |
NPD4772 |
Phase 2 |
0.7464 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7452 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7451 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7436 |
Intermediate Similarity |
NPD2563 |
Approved |
0.7436 |
Intermediate Similarity |
NPD2560 |
Approved |
0.7432 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7426 |
Intermediate Similarity |
NPD9384 |
Approved |
0.7426 |
Intermediate Similarity |
NPD9381 |
Approved |
0.7424 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7417 |
Intermediate Similarity |
NPD4584 |
Approved |
0.7413 |
Intermediate Similarity |
NPD554 |
Clinical (unspecified phase) |
0.7413 |
Intermediate Similarity |
NPD1726 |
Clinical (unspecified phase) |
0.7394 |
Intermediate Similarity |
NPD1024 |
Discontinued |
0.7394 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7391 |
Intermediate Similarity |
NPD2898 |
Approved |
0.7391 |
Intermediate Similarity |
NPD2233 |
Approved |
0.7391 |
Intermediate Similarity |
NPD2230 |
Approved |
0.7391 |
Intermediate Similarity |
NPD2232 |
Approved |
0.7379 |
Intermediate Similarity |
NPD2653 |
Approved |
0.7375 |
Intermediate Similarity |
NPD4010 |
Discontinued |
0.7372 |
Intermediate Similarity |
NPD2978 |
Approved |
0.7372 |
Intermediate Similarity |
NPD2977 |
Approved |
0.7365 |
Intermediate Similarity |
NPD1044 |
Clinical (unspecified phase) |
0.7351 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7343 |
Intermediate Similarity |
NPD5110 |
Phase 2 |
0.7343 |
Intermediate Similarity |
NPD5111 |
Phase 2 |
0.7343 |
Intermediate Similarity |
NPD5109 |
Approved |
0.7342 |
Intermediate Similarity |
NPD5604 |
Discontinued |
0.7338 |
Intermediate Similarity |
NPD9622 |
Approved |
0.7333 |
Intermediate Similarity |
NPD2219 |
Phase 1 |
0.732 |
Intermediate Similarity |
NPD2122 |
Discontinued |
0.732 |
Intermediate Similarity |
NPD6030 |
Approved |
0.732 |
Intermediate Similarity |
NPD6031 |
Approved |
0.7315 |
Intermediate Similarity |
NPD4236 |
Phase 3 |
0.7315 |
Intermediate Similarity |
NPD4237 |
Approved |
0.7308 |
Intermediate Similarity |
NPD5720 |
Discontinued |
0.7308 |
Intermediate Similarity |
NPD7945 |
Clinical (unspecified phase) |
0.7305 |
Intermediate Similarity |
NPD9619 |
Approved |
0.7305 |
Intermediate Similarity |
NPD9621 |
Approved |
0.7305 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.7305 |
Intermediate Similarity |
NPD9620 |
Approved |
0.7303 |
Intermediate Similarity |
NPD1771 |
Clinical (unspecified phase) |
0.7286 |
Intermediate Similarity |
NPD9634 |
Clinical (unspecified phase) |
0.7279 |
Intermediate Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.7279 |
Intermediate Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD3687 |
Approved |
0.7273 |
Intermediate Similarity |
NPD3686 |
Approved |
0.7267 |
Intermediate Similarity |
NPD6071 |
Discontinued |
0.7248 |
Intermediate Similarity |
NPD3655 |
Clinical (unspecified phase) |
0.7244 |
Intermediate Similarity |
NPD5089 |
Approved |
0.7244 |
Intermediate Similarity |
NPD5090 |
Approved |
0.7241 |
Intermediate Similarity |
NPD5837 |
Clinical (unspecified phase) |
0.7239 |
Intermediate Similarity |
NPD5602 |
Clinical (unspecified phase) |
0.7226 |
Intermediate Similarity |
NPD4017 |
Approved |
0.7226 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7226 |
Intermediate Similarity |
NPD7261 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD601 |
Approved |
0.7222 |
Intermediate Similarity |
NPD597 |
Approved |
0.7222 |
Intermediate Similarity |
NPD598 |
Approved |
0.7219 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD3692 |
Discontinued |
0.7214 |
Intermediate Similarity |
NPD1420 |
Approved |
0.7214 |
Intermediate Similarity |
NPD1421 |
Approved |
0.7211 |
Intermediate Similarity |
NPD6111 |
Discontinued |
0.7208 |
Intermediate Similarity |
NPD3641 |
Approved |
0.7208 |
Intermediate Similarity |
NPD3639 |
Approved |
0.7208 |
Intermediate Similarity |
NPD3640 |
Phase 3 |
0.7203 |
Intermediate Similarity |
NPD600 |
Approved |
0.7203 |
Intermediate Similarity |
NPD596 |
Approved |
0.72 |
Intermediate Similarity |
NPD2458 |
Approved |
0.72 |
Intermediate Similarity |
NPD2460 |
Phase 3 |
0.72 |
Intermediate Similarity |
NPD2459 |
Approved |
0.719 |
Intermediate Similarity |
NPD1424 |
Approved |
0.7181 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.7176 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7172 |
Intermediate Similarity |
NPD1130 |
Approved |
0.7172 |
Intermediate Similarity |
NPD1132 |
Approved |
0.7172 |
Intermediate Similarity |
NPD1423 |
Approved |
0.7172 |
Intermediate Similarity |
NPD1136 |
Approved |
0.7171 |
Intermediate Similarity |
NPD7124 |
Phase 2 |
0.7162 |
Intermediate Similarity |
NPD4108 |
Discontinued |
0.7162 |
Intermediate Similarity |
NPD3693 |
Clinical (unspecified phase) |
0.7161 |
Intermediate Similarity |
NPD2883 |
Discontinued |
0.716 |
Intermediate Similarity |
NPD4606 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD2235 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD2231 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD5314 |
Approved |
0.7143 |
Intermediate Similarity |
NPD1772 |
Clinical (unspecified phase) |
0.7133 |
Intermediate Similarity |
NPD7596 |
Clinical (unspecified phase) |
0.7123 |
Intermediate Similarity |
NPD3059 |
Approved |
0.7123 |
Intermediate Similarity |
NPD2238 |
Phase 2 |
0.7123 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7123 |
Intermediate Similarity |
NPD3061 |
Approved |
0.7123 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7123 |
Intermediate Similarity |
NPD3062 |
Approved |
0.7121 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7121 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7105 |
Intermediate Similarity |
NPD302 |
Approved |
0.7103 |
Intermediate Similarity |
NPD2028 |
Clinical (unspecified phase) |
0.7103 |
Intermediate Similarity |
NPD1039 |
Discontinued |
0.7101 |
Intermediate Similarity |
NPD8053 |
Approved |
0.7101 |
Intermediate Similarity |
NPD8054 |
Approved |
0.7099 |
Intermediate Similarity |
NPD2821 |
Approved |
0.7092 |
Intermediate Similarity |
NPD6583 |
Phase 3 |
0.7092 |
Intermediate Similarity |
NPD3685 |
Discontinued |
0.7092 |
Intermediate Similarity |
NPD6582 |
Phase 2 |
0.709 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7089 |
Intermediate Similarity |
NPD7298 |
Approved |
0.7083 |
Intermediate Similarity |
NPD7132 |
Clinical (unspecified phase) |
0.7073 |
Intermediate Similarity |
NPD27 |
Approved |
0.7073 |
Intermediate Similarity |
NPD677 |
Clinical (unspecified phase) |
0.7073 |
Intermediate Similarity |
NPD2489 |
Approved |
0.707 |
Intermediate Similarity |
NPD3296 |
Phase 1 |
0.707 |
Intermediate Similarity |
NPD5617 |
Suspended |
0.7068 |
Intermediate Similarity |
NPD9280 |
Clinical (unspecified phase) |
0.7063 |
Intermediate Similarity |
NPD7905 |
Discontinued |
0.7059 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7059 |
Intermediate Similarity |
NPD6783 |
Clinical (unspecified phase) |
0.7055 |
Intermediate Similarity |
NPD259 |
Phase 1 |
0.7051 |
Intermediate Similarity |
NPD950 |
Clinical (unspecified phase) |
0.7044 |
Intermediate Similarity |
NPD5563 |
Clinical (unspecified phase) |
0.704 |
Intermediate Similarity |
NPD9296 |
Approved |
0.7037 |
Intermediate Similarity |
NPD2228 |
Approved |
0.7037 |
Intermediate Similarity |
NPD2234 |
Approved |
0.7037 |
Intermediate Similarity |
NPD2229 |
Approved |
0.7035 |
Intermediate Similarity |
NPD6377 |
Clinical (unspecified phase) |
0.7027 |
Intermediate Similarity |
NPD2492 |
Phase 1 |
0.7025 |
Intermediate Similarity |
NPD6072 |
Discontinued |
0.7023 |
Intermediate Similarity |
NPD1444 |
Approved |
0.7023 |
Intermediate Similarity |
NPD1445 |
Approved |
0.7014 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7006 |
Intermediate Similarity |
NPD3111 |
Phase 1 |
0.7006 |
Intermediate Similarity |
NPD3866 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD1632 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD3156 |
Discontinued |
0.6993 |
Remote Similarity |
NPD5084 |
Clinical (unspecified phase) |
0.6987 |
Remote Similarity |
NPD6662 |
Clinical (unspecified phase) |
0.6985 |
Remote Similarity |
NPD595 |
Approved |
0.6985 |
Remote Similarity |
NPD593 |
Approved |
0.6972 |
Remote Similarity |
NPD4129 |
Approved |
0.6968
|
Remote Similarity |
NPD2874 |
Phase 2 |